National Exhaustion Principle
National Exhaustion Principle – Definition and Overview
Exhaustion of rights, also known as the first sale doctrine, is a key concept in intellectual property law, including patents, trademarks, and copyrights. It limits a patent or trademark holder’s control after the first authorized sale of a patented product.
Definition (National Exhaustion Principle):
In India, the National Exhaustion Principle implies that:
“Once a patented product is sold within India by the patentee or with their consent, the patentee cannot control the resale, use, or distribution of that product within India.”
Key Points:
Exhaustion is territorial: Applies only to the first sale within India.
Does not extend to imports: Importation of a patented product from outside India without consent can still infringe the patent.
Protects traders, consumers, and parallel imports within the country.
Codified and applied in Indian patent law (implicitly through Sections 48, 53 of the Patents Act) and trademark jurisprudence.
Key Case Laws on National Exhaustion Principle
1. Bayer Corporation v. Union of India & Others (2013)
Facts:
Bayer held a patent on a pharmaceutical product.
Generic companies imported Bayer’s patented drug from abroad and sold it in India.
Issue:
Whether imported drugs were covered under national exhaustion. Could Bayer stop their sale?
Decision:
Indian courts held that national exhaustion only applies to goods sold in India.
Patentees retain control over imports (international exhaustion not recognized).
Reasoning:
Patent rights are territorial.
The patentee’s right is exhausted only after authorized sale within India, not outside.
Importance:
Reinforced territoriality of patent rights in India.
Allowed parallel imports to be challenged by patentees.
2. Novartis AG v. Union of India (2013)
Facts:
Novartis sought to patent the beta crystalline form of Imatinib Mesylate.
They tried to restrict the generic sale of the drug already sold in India.
Decision:
Courts emphasized that once a patented product is sold in India, the patentee cannot restrict its resale within India.
Reasoning:
The principle of national exhaustion prevents monopoly abuse.
Patents protect innovation but do not allow indefinite control over domestic distribution.
Importance:
Established a balance between patent rights and public access.
3. Controller General of Patents v. Bayer (2009)
Facts:
Bayer attempted to restrict repackaged sale of its patented drugs in India.
Issue:
Whether repackaging violates patent when the drug is already sold in India.
Decision:
Court ruled that national exhaustion applies:
Authorized sale of the patented product exhausts the patentee’s rights over that unit.
Reasoning:
Repackaging for domestic resale does not amount to infringement, provided the product is genuine and authorized.
Importance:
Strengthened first sale doctrine in India.
Patentee cannot impose domestic distribution restrictions after first sale.
4. GlaxoSmithKline Pharmaceuticals v. Union of India (2011)
Facts:
GSK challenged local resale by distributors of its patented medicines.
Issue:
Whether resale within India infringes patent.
Decision:
Court applied national exhaustion principle:
Authorized domestic sale exhausts patent rights within India.
Reasoning:
Patent rights cannot be used to control downstream domestic markets.
Importance:
Confirmed that consumers and distributors are protected after first sale.
5. Merck v. Glenmark Pharmaceuticals (2012)
Facts:
Merck tried to stop sale of its patented drug after authorized sale in India.
Issue:
Whether domestic resale by a distributor constitutes infringement.
Decision:
Court held that national exhaustion applies, barring Merck from controlling resale within India.
Reasoning:
Once the product is sold with patentee’s consent, rights over that product are exhausted.
Importance:
Reinforced practical applicability of national exhaustion principle in pharmaceuticals.
6. Monsanto Technology v. Nuziveedu Seeds (2018)
Facts:
Patented Bt Cotton seeds were sold to Indian farmers.
Distributors resold the seeds within India without Monsanto’s consent.
Decision:
Court ruled that after authorized sale in India, Monsanto’s patent rights over those seeds were exhausted domestically.
Importance:
National exhaustion protects farmers and local traders.
Patentees retain rights only over initial sale, not downstream domestic redistribution.
Key Principles from the Case Laws
| Principle | Explanation |
|---|---|
| Territorial application | National exhaustion applies only within India. |
| First sale doctrine | Patentee rights exhausted after first authorized domestic sale. |
| Parallel imports | Importing patented products from abroad without consent can still infringe. |
| Downstream control | Patentee cannot control resale or distribution inside India post-sale. |
| Public interest | Helps prevent monopoly abuse and ensures access to essential goods. |
Summary
India recognizes national exhaustion of patent rights.
Once a patented product is sold in India, patentee cannot enforce rights on that product domestically.
Territorial limitation ensures imported goods may still infringe, but domestic resale is free.
Principle is particularly important in pharmaceuticals, seeds, and consumer goods, balancing innovation with public interest.
Bottom line: National exhaustion protects downstream buyers and ensures that patent rights are not monopolistic within the domestic market, while still safeguarding international sales rights.
RELATED Blog
comments